Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Svr-Hcv'

Svr-Hcv published presentations and documents on DocSlides.

HCV cure by IFN-free DAAs is associated with increased survival in patients with HCV-related HCC
HCV cure by IFN-free DAAs is associated with increased survival in patients with HCV-related HCC
by jovita
Hansen Dang,. 1,2*. Yee Hui Yeo,. 1*. Satoshi Ya...
Update on the HCV Antiviral Pipeline
Update on the HCV Antiviral Pipeline
by natalia-silvester
Todd S. Wills, MD. SPNS HCV Treatment Expansion I...
Alcohol Use in Chronic Hepatitis C Infection
Alcohol Use in Chronic Hepatitis C Infection
by cecilia
Lamia Haque. WHAT-IF Session. July 2019. Backgrou...
Taking Steps to Improve the Management
Taking Steps to Improve the Management
by mitsue-stanley
of Chronic HCV. This educational program and spea...
EASL 2019 HCV Conference Update
EASL 2019 HCV Conference Update
by sophia
April 10. –14. , 2019. Vienna, Austria. Disclaim...
HCV Clinical Management TRAINER(S)
HCV Clinical Management TRAINER(S)
by trish-goza
IAPAC African Regional Capacity-Building Hub. Bas...
HCV Clinical Management TRAINER(S)
HCV Clinical Management TRAINER(S)
by danika-pritchard
IAPAC African Regional Capacity-Building Hub. Bas...
Simplified HCV Therapy in 2018
Simplified HCV Therapy in 2018
by phoebe-click
This program is s. upported. by educational gran...
Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6
Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6
by pasty-toler
ASTRAL-1. Phase 3. . Treatment. . Naïve & ...
Sofosbuvir in HCV-
Sofosbuvir in HCV-
by mitsue-stanley
HIV Coinfection & HCV . GT 1,2,3. PHOTON-1 Tr...
Treatment with the second-generation HCV protease inhibitor
Treatment with the second-generation HCV protease inhibitor
by conchita-marotz
Results from SILEN-C1 in HCV genotype-1 treatment...
Future HCV Treatment Paradigms
Future HCV Treatment Paradigms
by kittie-lecroy
Mark Sulkowski, MD . Professor of Medicine. Medic...
SVRS 2015 SPRING ELECTION READINESS:
SVRS 2015 SPRING ELECTION READINESS:
by popsmolecules
Checklist . II. Have you completed the following:....
HCV Assays: Impact on HCV Studies
HCV Assays: Impact on HCV Studies
by blanko
& . Update on HCV . blood bank protocol. . Ov...
26/07/2013
26/07/2013
by alida-meadow
1. Le 29-01-2015. Les anticorps neutralisants ant...
Edited by
Edited by
by ellena-manuel
Morris Sherman MD . BCh. PhD FRCP(C) . Associate...
Marion G. Peters, MD John V. Carbone, MD, Endowed Chair
Marion G. Peters, MD John V. Carbone, MD, Endowed Chair
by ashley
Professor of Medicine. Chief of Hepatology Researc...
Confronting Hepatitis C and HIV Among the Homeless
Confronting Hepatitis C and HIV Among the Homeless
by delilah
Marguerite Beiser, ANP-BC, AAHIVS. Boston Health C...
Elbasvir-Grazoprevir in
Elbasvir-Grazoprevir in
by esther
HCV . GT 1,4, or 6 in PWID* on Opiate Agonist Ther...
Viral hepatitis Best of ILC 2019
Viral hepatitis Best of ILC 2019
by stella
About these slides. These slides provide highlight...
Viral hepatitis Best of ILC 2018
Viral hepatitis Best of ILC 2018
by roberts
About these slides. These slides provide highlight...
Daclatasvir + Sofosbuvir + RBV in GT3
Daclatasvir + Sofosbuvir + RBV in GT3
by sophia2
. with Advanced Liver Disease. ALLY-3+ Study. Phas...
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
by webraph
Sameh W. Boktor, MD, MPH. Medical Epidemiologist. ...
C-EDGE Co-Infected: Phase 3 Study of
C-EDGE Co-Infected: Phase 3 Study of
by giovanna-bartolotta
C-EDGE Co-Infected: Phase 3 Study of Grazoprevi...
Hepatitis C Imtiaz Alam, M.D.
Hepatitis C Imtiaz Alam, M.D.
by olivia-moreira
Medical Director, Austin Hepatitis Center. 1. Hep...
Hepatitis C: A New Era In Treatment And Cure
Hepatitis C: A New Era In Treatment And Cure
by myesha-ticknor
Adam . Deising. , DO. LCDR MC USN. Director of . ...
Updates in Treatment of Hepatitis C
Updates in Treatment of Hepatitis C
by myesha-ticknor
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:
by kittie-lecroy
Interim Analysis of a French Multicenter Compassi...
Updates in Treatment of Hepatitis C
Updates in Treatment of Hepatitis C
by cheryl-pisano
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
Resistance to Direct Acting Antiviral Therapy
Resistance to Direct Acting Antiviral Therapy
by tawny-fly
Resistance to HCV DAAs: What is the threat level...
May 3, 2016: Hepatitis C Kills More Americans than Any Other Infectious
May 3, 2016: Hepatitis C Kills More Americans than Any Other Infectious
by luanne-stotts
Disease. Annual Hepatitis . C-related mortality i...
What’s New in Hepatitis C
What’s New in Hepatitis C
by debby-jeon
Diana L. . Sylvestre. , MD. University of CA, San...
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
by lois-ondreau
Sameh W. Boktor, MD, MPH. Medical Epidemiologist....
ALLY-3 Design Objective SVR
ALLY-3 Design Objective SVR
by mitsue-stanley
12. (HCV RNA < 25 IU/ml), . with. 95% CI. DC...
Sofosbuvir-Velpatasvir in Genotype 2
Sofosbuvir-Velpatasvir in Genotype 2
by stefany-barnette
ASTRAL-2*. Phase 3. . Treatment. . Naïve &...
Sofosbuvir-Velpatasvir
Sofosbuvir-Velpatasvir
by trish-goza
in Genotype 3. ASTRAL-3. Phase 3. . Treatment. ...
Sofosbuvir in Genotypes 2 or 3
Sofosbuvir in Genotypes 2 or 3
by giovanna-bartolotta
VALENCE Trial. Phase . 3. Treatment. Naïve and ...
Daclatasvir in Combination With Sofosbuvir
Daclatasvir in Combination With Sofosbuvir
by mitsue-stanley
With Or Without Ribavirin Is Safe and Efficacious...
Real World Data
Real World Data
by kittie-lecroy
REAL-WORLD SAFETY AND EFFECTIVENESS OF OMBITASVIR...
Are Pan-Genotypic Therapies Ready for Prime Time?
Are Pan-Genotypic Therapies Ready for Prime Time?
by lois-ondreau
3. Rd. International . HIV/Hepatitis . Coinfecti...